Building a Global Network to Better Serve Our Customers
Where we come from
Belgian and Walloon ecosystem
Since the 90s, Wallonia has been a bio-manufacturing hub with the creation of several international companies.
Launch of Univercells
Creation of Exothera to relieve viral vector manufacturing bottlenecks
In 2020, Univercells launches Exothera to support cell & gene therapy developers with process development and production of viral vectors.
With 15,000m² GMP capabilities Exothera is willing to relieve viral vector manufacturing bottlenecks.
Exothera will help to alleviate the three most critical challenges manufacturers face:
- Structural lack of capacity and long lead times.
- Scarcity of bioprocessing expertise in process scale-up and commercial scale manufacturing.
- Challenges in right-sizing commercial facility.
Establish a full-service viral vector CDMO facility in the heart of Europe, accommodating sizeable production capabilities from R&D to clinical trial phases.